Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history now includes a new revision entry v3.3.4 and removes the previous entry v3.3.3. This is a minor platform update and does not affect the trial information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.3 was added to the history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history now adds Revision: v3.3.2 and removes Revision: v3.2.0; this is a minor metadata update to the record history that does not affect study data or status.SummaryDifference0.1%

- Check67 days agoChange DetectedThe site-wide government funding/operating status notice has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedThe new screenshot shows a visual refresh of the Record History page, with the same version entries and no changes to the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check110 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference9%

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.